Minimize Our Environmental Impact

Our purpose of making life better includes protecting and preserving the world we live in.

Making medicines requires the use of valuable resources including energy, water and raw materials. We’re committed to continually minimizing our environmental impact across our product life cycles and supply chain. We have set new sustainability goals to reduce our emissions and waste and to continue using water responsibly and efficiently.

This helps ensure that our operations are safe for our employees and for the communities where we operate, while minimizing our use of natural resources.

We set and measure challenging environmental goals to drive performance. See our latest environmental reporting.

State-Specific Requirements

Lilly supports the safe collection and proper disposal of syringes, needles and other sharps generated in home settings. For this reason and to comply with laws addressing sharps disposal, our Safe Sharps Disposal Plan is made available to the public on this website, along with more important compliance information.

Lilly CA Sharps Document, June 2022

Corporate Disclosure in Compliance with the California Transparency in Supply Chains Act of 2010

Lilly Cautionary Statement Regarding Forward-Looking Statements

This website contains forward-looking statements that are based on management’s assumptions and expectations at the time the statements were posted, including statements regarding our sustainability targets, goals, commitments and programs and other business plans, initiatives, aspirations and objectives. The words “estimate”, “project”, “intend”, “expect”, “believe”, “target”, “anticipate” and similar expressions are intended to identify forward-looking statements. All such statements are intended to enjoy the protection of the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995, as amended. Actual results may differ materially due to various factors. The company’s sustainability targets, goals, and commitments outlined in this website or elsewhere, as well as its operations, results, business, goals, and strategy may be affected by factors including, but not limited to, the impact of the evolving COVID-19 pandemic (or any other public health threat) and the global response thereto; the significant costs and uncertainties in the pharmaceutical research and development process, including with respect to the timing and process of obtaining regulatory approvals; competitive developments affecting current products and the company’s pipeline; regulatory actions regarding currently marketed products; litigation, investigations, or other similar proceedings involving past, current, or future products or commercial activities as the company is largely self-insured; the impact and outcome of business development transactions and related integration costs; the impact of global macroeconomic conditions, trade disruptions, disputes, unrest, war or other costs or uncertainties related to doing business in foreign jurisdictions; issues with product supply and regulatory approvals stemming from manufacturing difficulties, disruptions or shortages, including as a result of demand, labor shortages, third-party performance or regulatory actions relating to our facilities; and changes or developments in laws and regulations, including health care reform.

For additional information about the factors that affect the company’s business, please see the company’s latest Forms 10-K, 10-Q, and any 8-Ks filed with the Securities and Exchange Commission. The company expressly disclaims any obligation to update forward-looking statements except as required by applicable law.

Find more detail on Lilly’s environmental, social and governance priorities, strategies and operations.